Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment. – UroToday
Immunotherapy in urothelial cancer, part 2: adjuvant, neoadjuvant, and adjunctive treatment.UroTodayThis had led to a revisitation of immunotherapy in urothelial cancer, as well as the genesis of trials using novel immunotherapeutic agents. This review… Continue reading
